The combined approach allows for creating specific genetic models by introducing or correcting AD-associated mutations in genes such as APP, PSEN1, PSEN2, APOE, SORL1, ABCA7, and others, providing insights into the mechanisms underlying disease progression. Here, APP is linked to Alzheimer disease.